StockData
GCTKNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31

Glucotrack, Inc.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$0.68−0.04 (-5.56%)

Close on Oct 19, 2026

Market cap
$3.43M
P/E (TTM)
0.0
Dividend yield
–

Glucotrack, Inc. revenue by segment

AnnualQuarterlyTTM

No segment breakdown reported

Glucotrack does not break out revenue by segment, region or product in the tagged data of its filings for this period type.